MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies
Guest UserJuly 29, 2020
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics

Guest UserSeptember 10, 2020
Next

Merck KGaA, Darmstadt, Germany Takes an Early Option in Immuno-Oncology Collaboration

Guest UserJuly 16, 2020

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact